Craig McDonald, MD
University of California, Davis · UC Davis
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Craig McDonald, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:22 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05126758 · A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular DystrophyCapricor Inc. · active not recruiting · Muscular Dystrophies, Muscular Dystrophy, Duchenne, Muscular Disorders, Atrophic · principal investigator
- Ph2NCT04428476 · Open-label Extension of the HOPE-2 TrialCapricor Inc. · active not recruiting · Duchenne Muscular Dystrophy · principal investigator
- Ph2NCT03406780 · A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular DystrophyCapricor Inc. · completed · Muscular Dystrophies, Muscular Dystrophy, Duchenne, Muscular Disorders, Atrophic · principal investigator
- Ph3NCT01027884 · Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)Santhera Pharmaceuticals · completed · Muscular Dystrophy, Duchenne, Ambulatory Care · principal investigator
- N/ANCT00468832 · Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD)Cooperative International Neuromuscular Research Group · unknown · Duchenne Muscular Dystrophy · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.